期刊文献+

Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives 被引量:13

Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives
下载PDF
导出
摘要 Hepatocellular carcinoma(HCC),the predominant form of adult liver malignancies,is a global health concern.Its dismal prognosis has prompted recent significant advances in the understanding of its etiology and pathogenesis.The deregulation of epigenetic mechanisms,which maintain heritable gene expression changes and chromatin organization,is implicated in the development of multiple cancers,including HCC.This review summarizes the current knowledge of epigenetic mechanisms in the pathogenesis of HCC,with an emphasis on HCC mediated by chronic hepatitis B virus infection.This review also discusses the encouraging outcomes and lessons learnt from epigenetic therapies for hematological and other solid cancers,and highlights the future potential of similar therapies in the treatment of HCC. Hepatocellular carcinoma(HCC),the predominant form of adult liver malignancies,is a global health concern. Its dismal prognosis has prompted recent significant advances in the understanding of its etiology and pathogenesis. The deregulation of epigenetic mechanisms,which maintain heritable gene expression changes and chromatin organization,is implicated in the development of multiple cancers,including HCC. This review summarizes the current knowledge of epigenetic mechanisms in the pathogenesis of HCC,with an emphasis on HCC mediated by chronic hepatitis B virus infection. This review also discusses the encouraging outcomes and lessons learnt from epigenetic therapies for hematological and other solid cancers,and highlights the future potential of similar therapies in the treatment of HCC.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第2期333-345,共13页 世界胃肠病学杂志(英文版)
关键词 Hepatocellular carcinoma EPIGENETICS DNA methylation Histone modification miRNA lncRNA Hepatocellular carcinoma Epigenetics DNA methylati
  • 相关文献

参考文献12

  • 1Wen Wang,Lan-.luan Zhao,Hao Ren,Zhong-Tian Qi.Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma[J].World Journal of Gastroenterology,2012,18(38):5442-5453. 被引量:21
  • 2Shuang-FenTao,Chang-Song Zhang,Xian-Ling Guo,Yun Xu,Shan-Shan Zhang,Jian-Rui Song,Rong Li,Meng-Chao Wu,Li-XinWei.Anti-tumor effect of 5-aza-2'-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells[J].World Journal of Gastroenterology,2012,18(19):2334-2343. 被引量:13
  • 3Nicole C Tsim,Adam E Frampton,Nagy A Habib,Long R Jiao.Surgical treatment for liver cancer[J].World Journal of Gastroenterology,2010,16(8):927-933. 被引量:12
  • 4Massimo Negrini,Sabbioni,Gramantieri,Elamin,Elisa Callegari.Role of microRNAs in hepatocellular carcinoma: a clinical perspective[J].OncoTargets and Therapy (default).2013(default)
  • 5Cigdem Ozen,Gokhan Yildiz,Alper Tunga Dagcan,Dilek Cevik,Aysegul Ors,Umur Keles,Hande Topel,Mehmet Ozturk.Genetics and epigenetics of liver cancer[J].New BIOTECHNOLOGY.2013(4)
  • 6Xu, Xiaojie,Fan, Zhongyi,Kang, Lei,Han, Juqiang,Jiang, Chengying,Zheng, Xiaofei,Zhu, Ziman,Jiao, Huabo,Lin, Jing,Jiang, Kai,Ding, Lihua,Zhang, Hao,Cheng, Long,Fu, Hanjiang,Song, Yi,Jiang, Ying,Liu, Jiahong,Wang, Rongfu,Du, Nan,Ye, Qinong.Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis[J].Journal of Clinical Investigation.2013(2)
  • 7Mary Maluccio,Anne Covey.Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma[J].CA: A Cancer Journal for Clinicians.2012(6)
  • 8Ming-chun Lai,Zhe Yang,Lin Zhou,Qian-qian Zhu,Hai-yang Xie,Feng Zhang,Li-ming Wu,Lei-ming Chen,Shu-sen Zheng.Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation[J]. Medical Oncology . 2012 (3)
  • 9Chuanchao He,Junyao Xu,Jianlong Zhang,Dan Xie,Hua Ye,Zhiyu Xiao,Muyan Cai,Kang Xu,Yunjie Zeng,Haigang Li,Jie Wang.High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma[J].Human Pathology.2012(9)
  • 10Kuen-Tyng Lin,Yi-Wei Wang,Chiung-Tong Chen,Chun-Ming Ho,Wen-Hui Su,Yuh-Shan Jou.HDAC Inhibitors Augmented Cell Migration and Metastasis through Induction of PKCs Leading to Identification of Low Toxicity Modalities for Combination Cancer Therapy[J].Clinical Cancer Research.2012(17)

二级参考文献28

  • 1Patra SK, Bettuzzi S. Epigenetic DNA-(cytosine-5-carbon) modifications: 5-aza-2'-deoxycytidine and DNA-demethyl- ation. Biochemistry (Mosc) 2009; 74:613-619.
  • 2Fenaux l?, Ades L. Review of azacitidine trials in Interme- diate-2-and High-risk myelodysplastic syndromes. Leuk Res 2009; 33 Suppl 2:S7-S11.
  • 3Buckstein R, Yee K, Wells RA. 5-Azacytidine in myelodys- plastic syndromes: a clinical practice guideline. Cancer Treat Rev 2011; 37:160-167.
  • 4Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in hu- man disease and prospects for epigenetic therapy. Nature 2004; 429:457-463.
  • 5Altshuler ML, Severin SE, Glukhov AI. The tumor cell and telomerase. Biochemistry (Mosc) 2003; 68:1275-1283.
  • 6Oh BK, Kim H, Park YN, Yoo JE, Choi J, Kim KS, Lee JJ, Park C. High telomerase activity and long telomeres in ad- vanced hepatocellular carcinomas with poor prognosis. Lab Invest 2008; 88:144-152.
  • 7Hytiroglou P, Theise ND. Telomerase activation in human hepatocarcinogenesis. Am J Gastroenterol 2006; 101:839-841.
  • 8Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with im- mortal cells and cancer. Science 1994; 266:2011-2015.
  • 9Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, Yut- sudo M, Inoue M. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proxi- mal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 1999; 59:551-557.
  • 10Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M. Expres- sion of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res 1998; 58: 1558-1561.

共引文献64

同被引文献80

引证文献13

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部